Literature DB >> 23169314

Chronic obstructive pulmonary disease among adults--United States, 2011.

.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a group of progressive, debilitating respiratory conditions, including emphysema and chronic bronchitis, characterized by difficulty breathing, lung airflow limitations, cough, and other symptoms. COPD often is associated with a history of cigarette smoking and is the primary contributor to mortality caused by chronic lower respiratory diseases, which became the third leading cause of death in the United States in 2008. Despite this substantial disease burden, state-level data on the prevalence of COPD and associated health-care resource use in the United States have not been available for all states. To assess the state-level prevalence of COPD among adults, the impact of COPD on their quality of life, and the use of health-care resources by those with COPD, CDC analyzed data from the 2011 Behavioral Risk Factor Surveillance System (BRFSS). Among BRFSS respondents in all 50 states, the District of Columbia (DC), and Puerto Rico, 6.3% reported having been told by a physician or other health professional that they had COPD. In addition to the screening question asked of all respondents, 21 states, DC, and Puerto Rico elected to include an optional COPD module. Among persons who reported having COPD and completed the optional module, 76.0% reported that they had been given a diagnostic breathing test, 64.2% felt that shortness of breath impaired their quality of life, and 55.6% were taking at least one daily medication for their COPD. Approximately 43.2% of them reported visiting a physician for COPD-related symptoms in the previous 12 months, and 17.7% had either visited an emergency department or been admitted to a hospital for their COPD in the previous 12 months. Continued surveillance for COPD, particularly at state and local levels, is critical to 1) identify communities that likely will benefit most from awareness and outreach campaigns and 2) evaluate the effectiveness of public health efforts related to the prevention, treatment, and control of the disease.

Entities:  

Mesh:

Year:  2012        PMID: 23169314

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  145 in total

1.  How do patients conceptualize chronic obstructive pulmonary disease?

Authors:  R E Goldman; L Mennillo; P Stebbins; D R Parker
Journal:  Chron Respir Dis       Date:  2016-12-19       Impact factor: 2.444

2.  CT scan-measured pulmonary artery to aorta ratio and echocardiography for detecting pulmonary hypertension in severe COPD.

Authors:  Anand S Iyer; J Michael Wells; Sonia Vishin; Surya P Bhatt; Keith M Wille; Mark T Dransfield
Journal:  Chest       Date:  2014-04       Impact factor: 9.410

3.  The Long-Term Oxygen Treatment Trial for Chronic Obstructive Pulmonary Disease: Rationale, Design, and Lessons Learned.

Authors:  Roger D Yusen; Gerard J Criner; Alice L Sternberg; David H Au; Anne L Fuhlbrigge; Richard K Albert; Richard Casaburi; James K Stoller; Kathleen F Harrington; J Allen D Cooper; Philip Diaz; Steven Gay; Richard Kanner; Neil MacIntyre; Fernando J Martinez; Steven Piantadosi; Frank Sciurba; David Shade; Thomas Stibolt; James Tonascia; Robert Wise; William C Bailey
Journal:  Ann Am Thorac Soc       Date:  2018-01

4.  Effectiveness of Umeclidinium-Vilanterol for Protocolized Management of Chronic Obstructive Pulmonary Disease Exacerbation in Hospitalized Patients: A Sequential Period Analysis.

Authors:  Todd W Chapin; Michael A Mann; Gary L Brown; Traci L Leitheiser; Becky Anderson; David D Leedahl
Journal:  Chronic Obstr Pulm Dis       Date:  2018-01-24

5.  Respiratory symptoms, spirometric respiratory impairment, and respiratory disease in middle-aged and older persons.

Authors:  Brian S Marcus; Gail McAvay; Thomas M Gill; Carlos A Vaz Fragoso
Journal:  J Am Geriatr Soc       Date:  2015-01-30       Impact factor: 5.562

6.  Chronic Obstructive Pulmonary Disease in America's Black Population.

Authors:  Chinedu O Ejike; Mark T Dransfield; Nadia N Hansel; Nirupama Putcha; Sarath Raju; Carlos H Martinez; MeiLan K Han
Journal:  Am J Respir Crit Care Med       Date:  2019-08-15       Impact factor: 21.405

7.  Comparison between the EQ-5D-3L and the SF-6D quality of life (QOL) questionnaires in patients with chronic obstructive pulmonary disease (COPD) undergoing lung volume reduction surgery (LVRS).

Authors:  Sowmyanarayanan Thuppal; Stephen Markwell; Traves Crabtree; Stephen Hazelrigg
Journal:  Qual Life Res       Date:  2019-02-01       Impact factor: 4.147

8.  Disparate Rates of Utilization and Progression to Combined Heart Failure and Chronic Obstructive Pulmonary Disease among Asians and Pacific Islanders in Hawai'i.

Authors:  James Davis; Elizabeth Tam; Deborah Taira
Journal:  Hawaii J Med Public Health       Date:  2016-08

9.  Obesity Is Associated With Increased Morbidity in Moderate to Severe COPD.

Authors:  Allison A Lambert; Nirupama Putcha; M Bradley Drummond; Aladin M Boriek; Nicola A Hanania; Victor Kim; Gregory L Kinney; Merry-Lynn N McDonald; Emily P Brigham; Robert A Wise; Meredith C McCormack; Nadia N Hansel
Journal:  Chest       Date:  2016-08-25       Impact factor: 9.410

10.  Laryngopharyngeal symptoms in patients with chronic obstructive pulmonary disease.

Authors:  Abdul-Latif Hamdan; G Ziade; Z Turfe; N Beydoun; D Sarieddine; N Kanj
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-11-14       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.